Cargando…
Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
Despite advances in modern medicine, sepsis remains a complex syndrome that has been associated with significant morbidity and mortality. Multiple organ failure associated with sepsis leads to high mortality and morbidity. About 28 – 50% deaths have been reported in patients with sepsis. The number...
Autores principales: | Shukla, Aparna, Awasthi, Shilpi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016568/ https://www.ncbi.nlm.nih.gov/pubmed/21224965 http://dx.doi.org/10.4103/0019-5049.72637 |
Ejemplares similares
-
Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial
por: Shukla, Aparna
Publicado: (2012) -
Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?
por: Regnault, Veronique, et al.
Publicado: (2007) -
Acute effect of low-dose corticosteroids on muscle function in patients with severe sepsis and septic shock
por: Borges, RC, et al.
Publicado: (2009) -
Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017) -
Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
por: Yeo, In Kwon, et al.
Publicado: (2015)